Paladin Labs
Emily Ricci is an experienced quality management professional with a strong background in microbiology. Currently serving as an Interim Quality Manager at Paladin Pharma since August 2022, Emily previously held several roles at Jubilant Radiopharma, where responsibilities included leading quality control projects and managing non-conformance investigations. Emily's expertise extends to microbiology consulting at Amaris, focusing on regulatory compliance, training, and laboratory inspections. Earlier roles at Concentric involved overseeing fermentation operations and establishing quality control procedures in a cGMP environment. Emily began a research career at McGill University, culminating in a Master of Science in Microbiology.
This person is not in any offices
Paladin Labs
Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. Paladin has a focused marketing and sales organization that has helped it evolve into a well-known Canadian specialty pharmaceutical company with a breadth of products. Paladin is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.